APOE and Cognitive impairment: In comparison to patients with risk tau haplotypes and risk APOE variants, each one of the patients in GR1 (MAPT + TARDBP + TREM2 cases) had an earlier disease onset (without differences in disease duration), increased cognitive deficits, and a more minor presence of chronic symptoms.